menu ☰
menu ˟

Public Health Well

VIDEO: Kahook Dual Blade a vital part of surgeon’s MIGS strategy

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Jason Bacharach, MD, discusses how he incorporates use of the Kahook Dual Blade (New World Medical) in his MIGS strategy for the treatment of glaucoma. ...

Electric toothbrush helps prevent tooth loss

Using an electric toothbrush helps to prevent tooth loss, a new study has found. According to German researchers, while electric toothbrushes have become increasingly popular in recent years, ‘few studies have tested their long-term effectiveness'. Th ...

Health inequalities emerge in pre-school years

Children from poorer backgrounds are more likely to be overweight or obese from pre-school age onwards, researchers at Trinity College Dublin (TCD) have found. They carried out a study which followed over 41,000 children from childhood through to adolescen ...

Most think drinking is part of Irish culture

Over 20% of people who consume alcohol in Ireland are hazardous drinkers who face an increased risk of becoming dependent, a new report has found. According to the 2019 Drinkaware Index Report, 21% of the drinking population are already hazardous drinkers, ...

Warning over diabetes DIY technology

The national diabetes charity, Diabetes Ireland, has expressed concern about the use of so-called DIY (do it yourself) technology by some people with type 1 diabetes. Diabetes Ireland understands that there are a small number of people with type 1 diabetes ...

Many have poor understanding of MS

While most people say they are aware of the neurological condition, multiple sclerosis (MS), almost one-third cannot name a single symptom, new research has found. MS is a chronic disease of the central nervous system, which causes a gradual degeneration o ...

Doctors concerned about cannabis risks

Addiction treatment centres and psychiatric hospitals have recorded a big increase in the number of cannabis-related cases, and yet the Government is ‘sleepwalking' towards legalising the drug for medicinal purposes without considering the harms assoc ...

380,000 have witnessed recent adult abuse

As many as 380,000 adults in Ireland have witnessed the abuse of a vulnerable adult in the last year, but just 3% of these reported what they saw to an authority such as the Gardaí or HSE, new research has found. According to the findings, 10% of adults ha ...

Potentially FDA-approved medications face significant scrutiny on their printed materials

WASHINGTON — The FDA’s Office of Prescription Drug Promotion uses many methods to assess the validity of a potential medication’s print advertising, labels and other such materials for a particular medication before the agency can clear the materials for p ...

Hemoclips may not reduce post-polypectomy bleeding

SAN DIEGO — Prophylactic placement of hemoclips following the removal of large colon polyps did not decrease the risk for post-polypectomy bleeding, which questions the common practice of using hemoclips during polypectomy, according to the results of a pr ...

Whorlton Hall: Hospital abuse missed despite at least 100 official visits

Inspectors, council staff and NHS officials went in twice week on average in the year before Panorama expose. ...

Q&A: Battling HIV PrEP stigma with Rep. Brian Sims

May has been full of newsworthy stories about pre-exposure prophylaxis, or PrEP, for HIV prevention. First, Gilead Sciences announced that Truvada (emtricitabine/tenofovir disoproxil fumarate; FTC/TDF), a medication approved for the treatment and preventio ...

Regulation of data privacy may affect U.S. advancement in AI

WASHINGTON — Federal regulations regarding data privacy and collection may lead to the United States falling behind countries like China in developing artificial intelligence and neural networks for healthcare, a speaker said here. A bipartisan effort in t ...

More research needed to understand benefits, harms of cannabis for pain

SAN FRANCISCO — More research is needed to understand the harms and potential benefits of cannabis use among patients with chronic pain, Mark Ilgen, PhD, professor of psychiatry, director of the University of Michigan Addiction Treatment Services and resea ...

Iridex appoints new president, CEO

Iridex has named David Bruce as its new president and CEO, according to a press release. Bruce, who has been on the company’s board of directors since April 2018, previously served as CEO for several public and private medical device growth-stage companies ...

VIDEO: Physicians’ words guide patients from hopeless to hopeful

SAN DIEGO — In this video from Digestive Disease Week, William D. Chey, MD, professor of medicine, and director of the GI Physiology Laboratory at University of Michigan Health System, discusses a state-of-the-art lecture he gave during the conference that ...

Get your house in order: Prepare for private equity acquisition

With ever-increasing amounts of private equity flowing into health care, orthopedic surgeons are being approached by firms offering capital infusion or partnership arrangements. If your group is considering going this route, ensuring your “house” is in goo ...

Adjunct therapies desired to reduce ‘constant daily burden’ of type 1 diabetes

Adults with type 1 diabetes prioritize HbA1c time-in-target-range, weight loss and simple treatment procedures when evaluating their diabetes care, and there may be a substantial willingness to use adjunct therapies to achieve these goals, according to fin ...

Researchers say most 1-day follow-ups for cataract surgery are unnecessary

Researchers who analyzed current data on postoperative complications after uneventful phacoemulsification cataract surgery concluded that the postoperative 1-day follow-up may be unnecessary. Elimination of the postoperative day-1 (POD1) follow-up could si ...

Dupilumab lowers some infection rates in moderate to severe atopic dermatitis

Dupilumab decreased the risk for serious or severe infection and nonherpetic skin infections in patients with moderate to severe atopic dermatitis compared with placebo, according to results published in the American Journal of Clinical Dermatology. “In th ...